Peer review reports
From: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
Original Submission | ||
---|---|---|
20 Jan 2024 | Submitted | Original manuscript |
11 Mar 2024 | Reviewed | Reviewer Report - Gaetano Finocchiaro |
12 Mar 2024 | Reviewed | Reviewer Report |
7 Apr 2024 | Author responded | Author comments - Junping Zhang |
21 Apr 2024 | Reviewed | Reviewer Report - Nobuhiro Hata |
30 Apr 2024 | Reviewed | Reviewer Report - Gaetano Finocchiaro |
8 May 2024 | Author responded | Author comments - Junping Zhang |
Resubmission - Version 2 | ||
7 Apr 2024 | Submitted | Manuscript version 2 |
10 May 2024 | Author responded | Author comments - Junping Zhang |
Resubmission - Version 3 | ||
10 May 2024 | Submitted | Manuscript version 3 |
Publishing | ||
10 May 2024 | Editorially accepted | |
21 Jun 2024 | Article published | 10.1186/s12885-024-12373-9 |